Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$2.86
-1.89%
Mkt Cap $283.98M
Next Earnings
In 22 daysThu, May 21, 2026
EPS Estimate
-$0.41
4 analysts
Revenue Estimate
$1.67M
Last quarter: beat by +11.11% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$283.98M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.31